Recombinant Human Annexin A1/ANXA1 Protein

Recombinant Human Annexin A1 is produced by our E.coli expression system and the target gene encoding Ala2-Asn346 is expressed.

Introducing the Recombinant Human Annexin A1/ANXA1 Protein, a cutting-edge biotechnological advancement in the field of protein research. This meticulously engineered protein is derived from human sources, ensuring its utmost compatibility and functionality in various scientific applications.

The Recombinant Human Annexin A1/ANXA1 Protein exhibits exceptional purity and stability, making it an ideal choice for laboratory investigations and experimental studies. Its recombinant nature guarantees a consistent and reliable supply, eliminating concerns regarding batch-to-batch variability.

This protein's multifaceted properties enable its utilization in a wide range of research areas, including but not limited to immunology, cell biology, and molecular biology. Its ability to interact with phospholipids and calcium ions facilitates the exploration of intricate cellular processes, such as membrane dynamics and signal transduction pathways.

Furthermore, the Recombinant Human Annexin A1/ANXA1 Protein showcases remarkable anti-inflammatory and anti-tumor properties, making it an invaluable tool for investigating potential therapeutic interventions. Its involvement in regulating immune responses and modulating cellular apoptosis highlights its potential in the development of novel treatments for various diseases.

With its exceptional quality and versatility, the Recombinant Human Annexin A1/ANXA1 Protein stands as an indispensable asset for researchers and scientists alike. Unlock the potential of this remarkable protein and revolutionize your scientific endeavors with its unrivaled capabilities.